pharma · Dry Eye Disease
First Biotech (Australia)
Alcon Laboratories (Australia) Pty Ltd
Alcon Laboratories (Australia) is a pharma organization headquartered in AU. Primary therapeutic focus areas include Dry Eye Disease. NovaPharmaNews links 1 clinical program(s), 3 drug profile(s), and 0 patent record(s)
Melbourne, AU HQ
2017 Founded
2 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Melbourne, AU
- Founded
- 2017
- Employees
- 2
- Programs
- 1
- Drugs
- 4
- Patents
- 0
Hydroxypropyl Guar Galactomannan
Phase 2 · small molecule · Dry Eye Disease
Hydroxypropyl Guar Galactomannan for Dry Eye Disease is a Phase 2 program (small_molecule) at Alcon Laboratories (Australia) Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code C-07-54
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Alcon Laboratories (Australia) Pty Ltd
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Dry Eye Disease
- Status
- completed
- Trials
- 1